Page last updated: 2024-08-23

ursodeoxycholic acid and Weight Loss

ursodeoxycholic acid has been researched along with Weight Loss in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.33)	18.7374
1990's	9 (20.93)	18.2507
2000's	17 (39.53)	29.6817
2010's	11 (25.58)	24.3611
2020's	5 (11.63)	2.80

Authors

Authors	Studies
Conneely, JB; Fearon, NM; Heneghan, HM; Kearns, EC; Kennedy, CA	1
Andalib, A; Barzin, M; Hosseinpanah, F; Khalaj, A; Mahdavi, M; Mousapour, P; Valizadeh, M	1
Aljarad, F; Ameen, MA; Balamoun, H; Elewa, A; Elias, AA; Hamdy, A; Helal, A; Hussein, AM; Mahmoud, AA; Mohamed, US; Moustafa, A; Nashaat, A; Omar, HSE; Omar, T; Salman, A; Salman, MA; Shaaban, HE; Tourky, M	1
Alamro, N; Almuqati, A; Azhar, W; Azhri, AS; Azzeh, F; Ghafouri, K; Qadhi, A	1
Cai, J; Patterson, AD; Rivera, A; Theriot, CM; Winston, JA	1
Al Qatarneh, S; Lindblad, D; Michel, HK; Ozolek, J; Venkat, V; Weiner, DJ	1
Henry, L; Mehta, R; Mishra, A; Reyes, MJ; Younossi, ZM	1
Casper, M; Gluud, LL; Lammert, F; Stokes, CS	1
Colecchia, A; Festi, D; Villanova, N	1
Lammert, F; Stokes, CS	1
Calabrese, D; Coupaye, M; Ledoux, S; Msika, S; Sami, O	1
Daez, ML; Espinosa, WZ; Ong, JP; Talingdan-Te, MC; Uy, MC	1
Harrison, SA; Kashi, MR; Torres, DM	1
Andrieux, S; Bresson, R; Desbeaux, A; Fayard, A; Hec, F; Mulliez, E; Pruvot, MH	1
Jeong, SU; Lee, SK	1
Harrison, SA; Paredes, AH; Torres, DM	1
D'Aniello, R; De Micco, I; Lenta, S; Paolella, G; Parenti, G; Pignata, C; Salerno, M; Vajro, P	1
Hayem, G; Meyer, O; Pagnoux, C; Palazzo, E; Roux, F	1
Chung, KH; Kwon, YI; Oh, SM; Yeon, JD	1
Craanen, ME; Mijnhout, GS; Smulders, YM	1
Durian, MF; Hesp, WL; Kiewiet, RM; van Leersum, M; van Vliet, AC	1
Braegger, C	1
Harrison, SA; Neuschwander-Tetri, BA	1
Blum, HE	1
Dufour, JF; Oneta, CM	1
Galle, PR; Siebler, J	1
van Erpecum, KJ; Venneman, NG	1
Bateson, MC	1
Barshop, NJ; Lavine, JE; Schwimmer, JB; Sirlin, CB	1
Younossi, ZM	1
Brinkman-Kaplan, V; Kaplan, GD; Shiffman, ML; Vickers, FF	1
Brewer, WH; Brolin, RE; Fobi, MA; Linner, JH; MacDonald, KG; MacGregor, AM; Martin, LF; Oram-Smith, JC; Shiffman, ML; Sugerman, HJ	1
Marks, JW; Schoenfield, LJ; Stein, T	1
Inglis, FG; Shaffer, EA; Worobetz, LJ	1
Everhart, JE	1
Bonorris, GG; Marks, JW; Schoenfield, LJ	2
Milke, P; Morán, S; Rodríguez-Leal, G; Uribe, M	1
Colecchia, A; Festi, D; Larocca, A; Mazzella, G; Petroni, ML; Roda, E; Romano, F; Villanova, N	1
Allos, TM; Chapman, WC; Debelak, JP; Shyr, Y; Wright, JK; Wudel, LJ	1
Aldini, R; Bazzoli, F; Festi, D; Grigolo, B; Mazzella, G; Roda, A; Roda, E; Ronchi, M; Simoni, P; Villanova, N	1
Bonorris, GG; Broomfield, PH; Chopra, R; Marks, JW; Schoenfield, LJ; Sheinbaum, RC; Silverman, A	1

Reviews

19 review(s) available for ursodeoxycholic acid and Weight Loss

Article	Year
The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2022, Volume: 18, Issue:1 Topics: Bariatric Surgery; Gallstones; Humans; Obesity, Morbid; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid; Weight Loss	2022
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1 Topics: Bariatric Surgery; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Precision Medicine; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E; Weight Loss	2014
Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:7 Topics: Diet, High-Fat; Gallstones; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	2014
Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obesity surgery, 2008, Volume: 18, Issue:12 Topics: Bariatric Surgery; Cholagogues and Choleretics; Cholelithiasis; Humans; Obesity, Morbid; Postoperative Complications; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid; Weight Loss	2008
Current and emerging therapies in nonalcoholic fatty liver disease. Seminars in liver disease, 2008, Volume: 28, Issue:4 Topics: Animals; Antioxidants; Bariatric Surgery; Body Mass Index; Cannabinoids; Cholagogues and Choleretics; Comorbidity; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Lactones; Life Style; Metformin; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Thiazolidinediones; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	2008
Risk of biliary complications in bariatric surgery. Journal of visceral surgery, 2010, Volume: 147, Issue:4 Topics: Cholagogues and Choleretics; Cholecystectomy; Gallstones; Gastric Bypass; Gastroplasty; Humans; Postoperative Complications; Preoperative Care; Risk Factors; Ursodeoxycholic Acid; Weight Loss	2010
[Obesity and gallbladder diseases]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 59, Issue:1 Topics: Body Mass Index; Cholecystitis; Exercise; Gallbladder Diseases; Gallbladder Neoplasms; Gallstones; Humans; Hyperinsulinism; Hypolipidemic Agents; Insulin Resistance; Obesity; Ursodeoxycholic Acid; Weight Loss	2012
Nonalcoholic fatty liver disease. Clinics in liver disease, 2012, Volume: 16, Issue:2 Topics: Antioxidants; Biomarkers; Cholagogues and Choleretics; Diabetes Complications; Fatty Acids, Omega-3; Fatty Liver; Female; Free Radical Scavengers; Humans; Hypoglycemic Agents; Life Style; Middle Aged; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Ursodeoxycholic Acid; Weight Loss	2012
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. Italian journal of pediatrics, 2012, Oct-17, Volume: 38 Topics: Antioxidants; Bariatric Surgery; Child; Cholagogues and Choleretics; Fatty Acids, Omega-3; Fatty Liver; Humans; Hypoglycemic Agents; Life Style; Obesity; Overweight; Prebiotics; Probiotics; Ursodeoxycholic Acid; Weight Loss	2012
[Gallstones following considerable weight loss and recommendations for their prevention]. Nederlands tijdschrift voor geneeskunde, 2004, Jan-24, Volume: 148, Issue:4 Topics: Cholagogues and Choleretics; Diet, Fat-Restricted; Dietary Fats; Gallstones; Humans; Obesity; Ursodeoxycholic Acid; Weight Loss	2004
Pharmacologic management of nonalcoholic fatty liver disease. Clinics in liver disease, 2004, Volume: 8, Issue:3 Topics: Antihypertensive Agents; Antioxidants; Appetite Depressants; Fatty Liver; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Ursodeoxycholic Acid; Weight Loss	2004
[Hepatitis 2004: an update]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Antiviral Agents; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis, Alcoholic; Humans; Laparoscopy; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Physical Examination; Ultrasonography; Ursodeoxycholic Acid; Weight Loss	2004
[Alcoholic and non-alcoholic steatohepatitis]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Alcoholism; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Fatty Liver; Fatty Liver, Alcoholic; Gemfibrozil; Hepatitis; Hepatitis, Alcoholic; Humans; Hypolipidemic Agents; Insulin Resistance; Liver; Liver Transplantation; Middle Aged; Obesity; Pilot Projects; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones; Ultrasonography; Ursodeoxycholic Acid; Weight Loss	2004
Treatment of nonalcoholic fatty liver disease. World journal of gastroenterology, 2006, Apr-14, Volume: 12, Issue:14 Topics: Alanine Transaminase; Animals; Antioxidants; Body Mass Index; Fatty Liver; Humans; Hypolipidemic Agents; Liver Transplantation; Metformin; Pioglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid; Weight Loss	2006
Gallstone disease: Primary and secondary prevention. Best practice & research. Clinical gastroenterology, 2006, Volume: 20, Issue:6 Topics: Cholagogues and Choleretics; Cholecystectomy; Cholecystitis, Acute; Cholesterol; Diet; Female; Gallstones; Humans; Male; Pancreatitis; Risk Factors; Ursodeoxycholic Acid; Weight Loss	2006
Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:1 Topics: Adolescent; Adult; Antioxidants; Biomarkers; Child; Child, Preschool; Exercise Therapy; Fatty Liver; Female; Hepatocytes; Humans; Insulin Resistance; Male; Obesity; Oxidative Stress; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid; Weight Loss	2008
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:1 Topics: Antioxidants; Diabetes Mellitus, Type 2; Fatty Liver; Female; Humans; Hypolipidemic Agents; Insulin Resistance; Male; Obesity; Oxidative Stress; Risk Factors; Ursodeoxycholic Acid; Weight Loss	2008
Contributions of obesity and weight loss to gallstone disease. Annals of internal medicine, 1993, Nov-15, Volume: 119, Issue:10 Topics: Cholelithiasis; Diet, Reducing; Female; Humans; Male; Obesity; Risk Factors; Ursodeoxycholic Acid; Weight Loss	1993
Review: low caloric intake and gall-bladder motor function. Alimentary pharmacology & therapeutics, 2000, Volume: 14 Suppl 2 Topics: Bile Acids and Salts; Cholelithiasis; Cholesterol; Crystallization; Diet, Reducing; Dietary Fats; Energy Intake; Gastrointestinal Motility; Humans; Obesity; Ursodeoxycholic Acid; Weight Loss	2000

Trials

11 trial(s) available for ursodeoxycholic acid and Weight Loss

Article	Year
Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study. Surgical endoscopy, 2022, Volume: 36, Issue:9 Topics: Gallstones; Gastrectomy; Humans; Laparoscopy; Obesity, Morbid; Postoperative Complications; Prospective Studies; Ursodeoxycholic Acid; Weight Loss	2022
Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Annals of internal medicine, 1995, Jun-15, Volume: 122, Issue:12 Topics: Adolescent; Adult; Aged; Bile; Body Mass Index; Cholelithiasis; Cholesterol; Crystallization; Diet, Reducing; Double-Blind Method; Energy Intake; Female; Humans; Male; Middle Aged; Risk Factors; Ursodeoxycholic Acid; Weight Loss	1995
A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. American journal of surgery, 1995, Volume: 169, Issue:1 Topics: Adolescent; Adult; Cholelithiasis; Double-Blind Method; Female; Gastric Bypass; Humans; Male; Middle Aged; Placebos; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	1995
Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man. Digestive diseases and sciences, 1994, Volume: 39, Issue:9 Topics: Adult; Cholelithiasis; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid; Weight Loss	1994
The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. The American journal of gastroenterology, 1993, Volume: 88, Issue:10 Topics: Adult; Cholelithiasis; Female; Gastroplasty; Humans; Incidence; Male; Middle Aged; Obesity, Morbid; Ursodeoxycholic Acid; Weight Loss	1993
Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss. Digestive diseases and sciences, 1996, Volume: 41, Issue:2 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bile; Cholagogues and Choleretics; Cholelithiasis; Diet, Reducing; Double-Blind Method; Female; Gallbladder Emptying; Gastrointestinal Agents; Humans; Ibuprofen; Male; Obesity; Ursodeoxycholic Acid; Weight Loss	1996
Ref: Gallstone formation in obese subjects undergoing a weight reduction diet. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1998, Volume: 22, Issue:3 Topics: Adult; Cathartics; Cholagogues and Choleretics; Cholelithiasis; Cohort Studies; Diet, Reducing; Double-Blind Method; Female; Follow-Up Studies; Humans; Middle Aged; Obesity; Psyllium; Time Factors; Ursodeoxycholic Acid; Weight Loss	1998
Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. The Journal of surgical research, 2002, Volume: 102, Issue:1 Topics: Adult; Cholecystectomy; Cholelithiasis; Double-Blind Method; Female; Gastric Bypass; Humans; Ibuprofen; Male; Obesity, Morbid; Patient Compliance; Pilot Projects; Placebos; Time Factors; Ultrasonography; Ursodeoxycholic Acid; Weight Loss	2002
Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight. Digestive diseases and sciences, 1991, Volume: 36, Issue:7 Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Cholelithiasis; Cholesterol; Deoxycholic Acid; Dinoprostone; Double-Blind Method; Glycoproteins; Humans; Obesity; Ursodeoxycholic Acid; Weight Loss	1991
Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction. Gastroenterology, 1991, Volume: 101, Issue:2 Topics: Adolescent; Adult; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Drug Evaluation; Female; Humans; Male; Middle Aged; Obesity; Phospholipids; Ursodeoxycholic Acid; Weight Loss	1991
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. The New England journal of medicine, 1988, Dec-15, Volume: 319, Issue:24 Topics: Adult; Aspirin; Bile; Cholelithiasis; Cholesterol; Crystallization; Deoxycholic Acid; Double-Blind Method; Female; Glycoproteins; Humans; Male; Ursodeoxycholic Acid; Weight Loss	1988

Other Studies

13 other study(ies) available for ursodeoxycholic acid and Weight Loss

Article	Year
Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study. Obesity surgery, 2022, Volume: 32, Issue:2 Topics: Bariatric Surgery; Gallstones; Humans; Iran; Laparoscopy; Obesity; Obesity, Morbid; Postoperative Complications; Ursodeoxycholic Acid; Weight Loss	2022
Factors influencing body weight one year after bariatric surgery. Medicine, 2023, Mar-17, Volume: 102, Issue:11 Topics: Bariatric Surgery; Body Mass Index; Gallstones; Humans; Obesity, Morbid; Retrospective Studies; Ursodeoxycholic Acid; Weight Loss	2023
Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice. PloS one, 2021, Volume: 16, Issue:2 Topics: Animals; Body Weight; Cecum; Feces; Female; Gastrointestinal Microbiome; Ileum; Male; Metabolome; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Ursodeoxycholic Acid; Weight Loss	2021
Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis. The Journal of pediatrics, 2018, Volume: 203 Topics: Abdominal Pain; Adolescent; Biopsy; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Constipation; Contraceptives, Oral; Cystic Fibrosis; Female; Humans; Jaundice; Liver; Liver Diseases; Lung Diseases; Ovarian Cysts; Pancreas; Pancreatic Cyst; Pruritus; Radiography, Abdominal; Tomography, X-Ray Computed; Ursodeoxycholic Acid; Weight Loss	2018
Risk factors for gallstone formation during weight loss. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:3 Topics: Diet, High-Fat; Gallstones; Humans; Ursodeoxycholic Acid; Weight Loss	2015
Reply: To PMID 24321208. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:3 Topics: Diet, High-Fat; Gallstones; Humans; Ursodeoxycholic Acid; Weight Loss	2015
Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2017, Volume: 13, Issue:4 Topics: Adult; Bariatric Surgery; Body Mass Index; Cholagogues and Choleretics; Cholelithiasis; Female; Follow-Up Studies; France; Humans; Incidence; Male; Postoperative Complications; Retrospective Studies; Ursodeoxycholic Acid; Weight Loss	2017
[Gastroenterology and hepatology. Using established therapies]. MMW Fortschritte der Medizin, 2010, Dec-02, Volume: 152, Issue:48 Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Evidence-Based Medicine; Fatty Liver, Alcoholic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Mesalamine; Ursodeoxycholic Acid; Weight Loss	2010
[Sclerosing cholangitis as a complication of Langerhans'cell histiocytosis]. La Revue de medecine interne, 2003, Volume: 24, Issue:5 Topics: Abdominal Pain; Age Factors; Anti-Inflammatory Agents; Biopsy, Needle; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diabetes Insipidus; Disease Progression; Drug Therapy, Combination; Endosonography; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prognosis; Rare Diseases; Time Factors; Tomography, X-Ray Computed; Ursodeoxycholic Acid; Weight Loss	2003
Protective effects of ursodeoxycholic acid against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced testicular damage in mice. Toxicology and applied pharmacology, 2004, Feb-01, Volume: 194, Issue:3 Topics: Animals; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Organ Size; Polychlorinated Dibenzodioxins; Spermatogenesis; Teratogens; Testicular Diseases; Testicular Hormones; Testis; Ursodeoxycholic Acid; Weight Loss	2004
[Gallstones following considerable weight loss and recommendations for their prevention]. Nederlands tijdschrift voor geneeskunde, 2004, May-08, Volume: 148, Issue:19 Topics: Adult; Female; Gallstones; Humans; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	2004
NASH remains without a treatment ... URSO they say. Journal of pediatric gastroenterology and nutrition, 2004, Volume: 39, Issue:3 Topics: Child; Cholagogues and Choleretics; Fatty Liver; Humans; Pilot Projects; Safety; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	2004
Gallstones: Article was disappointing. BMJ (Clinical research ed.), 2007, Aug-25, Volume: 335, Issue:7616 Topics: Cholagogues and Choleretics; Cholecystectomy; Gallstones; Humans; Magnetic Resonance Imaging; Postoperative Complications; United States; Ursodeoxycholic Acid; Weight Loss	2007